MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
Location: United Kingdom, England, Oxford
Employees: 1-10
Founded date: 2021
Investors 3
Mentions in press and media 2
| Date | Title | Description |
| 14.12.2023 | MitoRx Therapeutics Closes Seed Extension Financing | MitoRx Therapeutics, an Oxford, UK-based biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, raised an undisclosed amount in additional seed funding.... |
| 25.04.2022 | MitoRx Therapeutics Raises Seed Financing | MitoRx Therapeutics, an Oxford, England, UK-based biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, closed its seed financing. The financial detail... |